ERCC1 and colorectal cancer: Our in vitro and in vivo results indicate that ERCC1 overexpression triggered colorectal cancer radioresistance; therefore, we believe that ERCC1 levels may affect chemotherapy and radiation therapy efficacy via DNA repair.